Apollo Endosurgery (APEN) stock price, revenue, and financials

Apollo Endosurgery market cap is $120.9 m, and annual revenue was $42.05 m in FY 2020
View Company

$120.9 M

APEN Mkt cap, 26-Feb-2021

$42 M

Apollo Endosurgery Revenue FY, 2020
Apollo Endosurgery Gross profit (FY, 2020)22.2 M
Apollo Endosurgery Gross profit margin (FY, 2020), %52.9%
Apollo Endosurgery Net income (FY, 2020)-22.6 M
Apollo Endosurgery EBIT (FY, 2020)-15.8 M
Apollo Endosurgery Cash, 31-Dec-202036.2 M
Apollo Endosurgery EV141.9 M

Apollo Endosurgery Revenue

Apollo Endosurgery revenue was $42.05 m in FY, 2020

Embed Graph

Apollo Endosurgery Revenue Breakdown

Embed Graph

Apollo Endosurgery revenue breakdown by business segment: 55.8% from Endoscopic Suturing System, 33.2% from Intragastric Balloon, 7.3% from Surgical and 3.7% from Other

Apollo Endosurgery revenue breakdown by geographic segment: 43.2% from US and 56.8% from Non US

Apollo Endosurgery Income Statement

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

64.3m60.9m50.7m42.0m

Revenue growth, %

(5%)(17%)

Cost of goods sold

24.6m27.7m25.0m19.8m

Gross profit

39.7m33.2m25.7m22.2m

Gross profit Margin, %

62%55%51%53%

Sales and marketing expense

32.9m32.8m28.7m17.4m

R&D expense

8.3m12.2m10.4m7.7m

General and administrative expense

13.7m13.4m13.6m11.1m

Operating expense total

62.2m73.3m49.2m38.0m

Depreciation and amortization

7.2m7.1m2.1m1.9m

EBIT

(22.4m)(40.1m)(23.5m)(15.8m)

EBIT margin, %

(35%)(66%)(46%)(38%)

Interest expense

4.5m4.1m4.1m5.3m

Pre tax profit

(27.0m)(45.6m)(27.2m)(22.5m)

Income tax expense

304.0k191.0k275.0k142.0k

Net Income

(27.3m)(45.8m)(27.4m)(22.6m)

EPS

(2.0)(2.3)(1.3)

Quarterly

USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

15.7m15.8m14.1m13.2m14.3m11.3m10.7m5.6m12.8m

Cost of goods sold

6.6m6.6m6.4m6.0m7.1m5.8m5.1m3.2m5.8m

Gross profit

9.2m9.2m7.7m7.2m7.2m5.4m5.6m2.4m7.0m

Gross profit Margin, %

58%58%55%55%50%48%53%43%54%

Sales and marketing expense

9.2m8.5m7.3m7.7m7.8m6.5m6.3m2.3m4.2m

R&D expense

2.5m3.2m3.0m3.4m2.7m2.1m2.1m1.8m1.5m

General and administrative expense

3.3m3.2m3.0m3.7m3.3m3.2m3.3m2.2m2.4m

Operating expense total

16.8m16.7m15.8m9.8m14.4m12.3m12.3m6.7m8.6m

Depreciation and amortization

1.8m1.8m1.8m553.0k528.0k510.0k496.0k490.0k486.0k

EBIT

(7.6m)(7.5m)(8.1m)(2.5m)(7.2m)(6.9m)(6.7m)(4.3m)(1.6m)

EBIT margin, %

(48%)(48%)(57%)(19%)(50%)(61%)(62%)(76%)(12%)

Interest expense

960.0k1.0m1.0m959.0k669.0k1.2m1.2m1.3m1.3m

Pre tax profit

(8.1m)(9.5m)(9.7m)(2.8m)(8.8m)(8.6m)(10.2m)(6.2m)(2.6m)

Income tax expense

58.0k28.0k36.0k51.0k80.0k43.0k6.0k41.0k

Net Income

(8.1m)(9.5m)(9.8m)(2.8m)(8.8m)(8.7m)(10.3m)(6.3m)(2.6m)

EPS

(0.5)(0.5)(0.4)(0.1)(0.4)(0.4)(0.5)(0.3)(0.1)

Apollo Endosurgery Balance Sheet

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

30.5m24.0m29.9m36.2m

Accounts Receivable

11.7m11.4m9.2m8.2m

Prepaid Expenses

1.0m2.8m3.0m3.8m

Inventories

14.3m9.9m8.9m10.3m

Current Assets

57.6m48.1m51.0m58.5m

PP&E

6.9m5.9m6.6m

Goodwill

6.8m5.3m5.3m5.3m

Total Assets

109.1m74.5m74.6m77.4m

Accounts Payable

18.3m15.3m9.9m3.7m

Short-term debt

34.4m636.0k

Current Liabilities

25.8m24.4m52.8m11.7m

Long-term debt

33.3m21.2m18.6k56.6m

Total Debt

33.3m21.2m34.5m57.2m

Total Liabilities

59.1m45.6m72.5m70.7m

Common Stock

17.0k22.0k21.0k26.0k

Additional Paid-in Capital

225.1m249.1m250.6m276.6m

Retained Earnings

(177.0m)(222.8m)(250.2m)(272.8m)

Total Equity

49.9m28.8m2.1m6.8m

Debt to Equity Ratio

0.7 x0.7 x16.2 x

Debt to Assets Ratio

0.3 x0.3 x0.5 x

Financial Leverage

2.2 x2.6 x35.1 x11.5 x

Quarterly

USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

22.3m34.4m28.4m30.0m22.9m35.0m23.2m19.1m37.4m

Accounts Receivable

11.9m11.5m10.3m10.6m11.2m8.9m7.5m5.7m8.2m

Prepaid Expenses

1.3m1.3m1.1m3.3m3.1m3.4m3.1m3.0m2.7m

Inventories

15.4m15.0m13.3m10.4m10.6m10.8m10.2m11.0m10.0m

Current Assets

50.9m62.1m53.1m54.3m47.8m58.1m44.1m38.8m58.4m

PP&E

6.9m6.9m6.7m8.0m7.4m7.0m6.2m5.6m6.7m

Goodwill

6.8m6.8m6.8m5.3m5.3m5.3m5.3m5.3m5.3m

Total Assets

100.6m110.4m99.6m82.3m74.7m84.2m66.7m60.1m80.7m

Accounts Payable

18.8m14.3m13.4m8.1m9.3m10.2m9.5m7.2m3.4m

Short-term debt

34.5m5.4m8.3m

Current Liabilities

25.7m21.7m22.0m19.6m21.4m20.3m52.6m19.1m19.0m

Long-term debt

33.1m33.3m31.0m33.9m33.9m52.8m18.6m50.9m48.8m

Total Debt

33.1m33.3m31.0m33.9m33.9m52.8m53.1m56.2m57.2m

Total Liabilities

58.8m55.0m53.0m56.7m56.6m74.3m72.2m70.7m70.3m

Common Stock

17.0k22.0k22.0k22.0k22.0k21.0k21.0k21.0k24.0k

Additional Paid-in Capital

225.5m248.3m248.8m249.4m249.8m250.2m251.5m252.0m275.9m

Retained Earnings

(185.2m)(194.7m)(204.5m)(225.5m)(234.3m)(243.0m)(260.4m)(266.7m)(269.3m)

Total Equity

41.8m55.5m46.6m25.5m18.0m9.9m(5.5m)(10.6m)10.4m

Debt to Equity Ratio

0.8 x0.6 x0.7 x1.3 x1.9 x5.3 x-9.7 x-5.3 x5.5 x

Debt to Assets Ratio

0.3 x0.3 x0.3 x0.4 x0.5 x0.6 x0.8 x0.9 x0.7 x

Financial Leverage

2.4 x2 x2.1 x3.2 x4.1 x8.5 x-12.2 x-5.7 x7.7 x

Apollo Endosurgery Cash Flow

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(27.3m)(45.8m)(27.4m)(22.6m)

Depreciation and Amortization

9.7m9.3m4.1m

Accounts Receivable

(916.0k)(162.0k)1.9m1.1m

Inventories

(2.8m)3.0m872.0k(1.6m)

Accounts Payable

4.7m(1.3m)(2.1m)(7.1m)

Cash From Operating Activities

(13.3m)(23.1m)(25.6m)(20.8m)

Purchases of PP&E

(1.6m)(2.0m)(805.0k)(486.0k)

Cash From Investing Activities

(2.1m)7.1m1.0m1.4m

Long-term Borrowings

(7.0m)(12.5m)(21.7m)

Cash From Financing Activities

26.7m9.7m30.5m25.6m

Net Change in Cash

11.4m(6.4m)5.9m6.3m

Interest Paid

3.8m3.8m3.5m3.2m

Income Taxes Paid

274.0k98.0k328.0k192.0k

Quarterly

USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

(8.1m)(17.7m)(27.4m)(2.8m)(11.6m)(20.2m)(10.3m)(16.5m)(19.1m)

Depreciation and Amortization

2.4m4.7m7.0m1.1m2.2m3.1m955.0k1.9m2.8m

Accounts Receivable

62.0k(90.0k)1.1m790.0k117.0k2.1m1.4m3.3m930.0k

Inventories

(1.2m)(1.0m)439.0k(502.0k)(659.0k)(1.0m)(1.5m)(2.3m)(1.3m)

Accounts Payable

272.0k(3.7m)(3.0m)1.6m1.6m97.0k15.0k(4.6m)(7.3m)

Cash From Operating Activities

(6.7m)(16.2m)(18.9m)(6.1m)(12.7m)(18.9m)(6.3m)(13.3m)(18.0m)

Purchases of PP&E

(1.2m)(1.5m)(2.0m)(112.0k)(377.0k)(466.0k)(272.0k)(388.0k)(431.0k)

Cash From Investing Activities

(1.3m)(1.9m)(2.7m)(177.0k)(458.0k)(629.0k)(318.0k)(458.0k)(548.0k)

Long-term Borrowings

(2.5m)(21.7m)(21.7m)(21.7m)

Cash From Financing Activities

(250.0k)22.2m19.7m12.2m12.1m30.6m(206.0k)2.6m25.8m

Net Change in Cash

(8.2m)4.0m(2.0m)6.0m(1.1m)11.0m(6.9m)(11.2m)7.3m

Interest Paid

889.0k1.8m2.7m1.2m1.8m2.6m814.0k1.6m2.4m

Income Taxes Paid

14.0k42.0k36.0k32.0k132.0k7.0k13.0k52.0k

Apollo Endosurgery Ratios

USDFY, 2017

Revenue/Employee

302.0k

Debt/Equity

0.7 x

Debt/Assets

0.3 x

Financial Leverage

2.2 x

Apollo Endosurgery Employee Rating

3.224 votes
Culture & Values
3.2
Work/Life Balance
3.3
Senior Management
2.9
Salary & Benefits
3.5
Career Opportunities
3
Source
View Apollo Endosurgery profile

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Learn more